CrowdStrike CTO Elia Zaitsev Exits After 13 Years to Start AI Security Venture Fund
Concerns grow over leadership continuity, product plans, and AI security efforts.
Already have an account? Sign in.
Concerns grow over leadership continuity, product plans, and AI security efforts.
CELZ-201 (Olastrocel) ADAPT trial fully enrolled and treated, including opioid patients. Clean safety profile and meaningful pain relief at 180 days; advancing toward RMAT review.
Virtu Financial is exploring a potential $3.5–4 billion sale of its agency brokerage and algos division in early-stage talks, sources say.
Deere posts first profit rise in 3 years, beats estimates and lifts 2026 guidance as strong construction demand offsets farm equipment weakness.